약학대학 전임교수 목록

교수진/연구실
교수진
전임교수

교수정보의 상세 화면
이름 전상민 학력 박사 전공 약학전공(과)
정보	연구실 : 약학관207호 연구실번호 : 3457 이메일 : smjeon@ajou.ac.kr 연구관심분야 : Cancer Metabolism and Signaling Network
학력	졸업연도/학교/학위 2011.05 University of Illinois at Chicago 박사 졸업연도/학교/학위 2001.02 서울대학교 석사 졸업연도/학교/학위 1999.02 서울대학교 학사
경력	2012.1~2013,7, Postdoctoral fellow, Research Oncology, Genentech, CA 2001.3~2005.9, Research Scientist, Samsung Biomedical Research Institute, Korea
연구분야	Lab of Integrative Cancer Signaling and Metabolism Network The international cancer genome project has provided comprehensive repertoire of novel oncogenic mutations at the genomic, epigenomic and transcriptomic levels in many tumor types. In the post-cancer genomics era, cancer research is now focused on defining the functional roles of these novel oncogenes and tumor suppressor genes and exploiting them for targeted cancer therapy. However, given that these oncogenic mutations are numerous and even heterogeneous in many tumors, targeting each individual gene should not be an ideal or promising therapeutic strategy. Thus, understanding the most critical convergent downstream of these diverse oncogenic signaling should be indispensable to warrant successful cancer therapy. Recently, a growing body of evidence has convincingly shown that diverse oncogenic signaling pathways converge on the regulation of cell metabolism to support energetic demand for deregulated cancer cell growth, proliferation and survival. In this aspect, cancer metabolism research has become emerging hallmark of cancer and one of the hottest fields in cancer research. In this view, our lab is interested in studying complex network between oncogenic mutations, signaling and metabolic pathways. We now focus on resolving fundamental and important questions to understand this network by employing bioinformatics, proteomics and metabolomics with in vitro & in vivo genetics tools. 1)Which metabolites/metabolic pathways and oncogenic signaling are regulated by diverse genetic & epigenetic mutations in each tumor type? 2)How these mutations regulate signal transduction and metabolic pathways? 3)How these altered metabolism or metabolic pathways contribute to cancer genesis or maintenance. 4)Validate identified metabolites or metabolic pathways as potential therapeutic targets as well as diagnostic markers for cancer. Finally, our long-term goal is to establish diet-metabolism-cancer connection, which will lead us to develop promising strategies for chemoprevention as well as cancer therapy.
논문 및 연구활동	연구활동(주요논문) [논문] 전상민, 최은지, NRF2-driven redox metabolism takes center stage in cancer metabolism from an outside-in perspective , ARCHIVES OF PHARMACAL RESEARCH , pp.321 -336 (Mar, 2020) [논문] 전상민, 신은애, Exploring vitamin D metabolism and function in cancer , EXPERIMENTAL AND MOLECULAR MEDICINE , pp.1 -14 (Apr, 2018) [논문] 전상민, 정병진, 이선형, 장수환, 신은애, 김수열, 고현정, 최은지, 유환식, A clinical drug library screen identifies clobetasol propionate as an NRF2 inhibitor with potential therapeutic efficacy in KEAP1 mutant lung cancer , ONCOGENE , pp.1 -11 (May, 2017) [논문] 전상민, Regulation and Function of AMPK in Physiology and Diseases , EXPERIMENTAL AND MOLECULAR MEDICINE , pp.1 -13 (Jul, 2016) [논문] 전상민, Nissim Hay, Naveedip Chandel, AMPK regulates NADPH homeostasis to promote tumour cell survival during energy stress , NATURE , Vol.485 , pp.661 -665 (May, 2012) 국제학술논문지 [논문] 전상민, Anju Singh, Shyam Biswal, Anneleen Daemen, Dorothee Nickles, Georgia Hatzivassiliou, Oded Foreman, Florian Gnad, Buvana Ravishankar, Amy Rappaport, Namrata Patil, Mark McCleland, Leisa Johnson, Kuladeep Sudini, Stephane Lajoie, Edward Gabrielson, Naina Gour, Wayne Mitzner, Samit Chatterjee, George Acquaah-Mensah, 최은지, NRF2 activation promotes aggressive lung cancer and associates with poor clinical outcomes , CLINICAL CANCER RESEARCH (Oct, 2020) [논문] 신수영, 최여진, 전상민, Impact of a Ketogenic Diet on Metabolic Parameters in Patients with Obesity or Overweight and with or without Type 2 Diabetes: A Meta-Analysis of Randomized Controlled Trials , NUTRIENTS , pp.1 -19 (Jul, 2020) [논문] 신수영, 채정우, 정현주, 윤휘열, 전상민, 박영준, Vancomycin Dosage and Its Association with Clinical Outcomes in Pediatric Patients with Gram-Positive Bacterial Infections , RISK MANAGEMENT AND HEALTHCARE POLICY , pp.685 -695 (Jun, 2020) [논문] 박성혁, Tin Tin Manh Nguyen, 안용진, 이하니, 고윤주, 이준호, Christine Chung, 전상민, 차진욱, Real-Time In-Organism NMR Metabolomics Reveals Different Roles of AMP-Activated Protein Kinase Catalytic Subunits , ANALYTICAL CHEMISTRY , pp.7382 -7387 (May, 2020) [논문] 전상민, 최은지, NRF2-driven redox metabolism takes center stage in cancer metabolism from an outside-in perspective , ARCHIVES OF PHARMACAL RESEARCH , pp.321 -336 (Mar, 2020) [논문] Yaoqi Zhou, Nicholas A. Kurniawan, Aik-Choon Tan, Mohamed A. El-Esawi, Thomas Liehr, Oliver Blanck, Douglas P. Gladue, Gabriel M. F. Almeida, Tomislav Cernava, Carlos O. Sorzano, Andy W. K. Yeung, Michael S. Engel, Arun Richard Chandrasekaran, Thilo Muth, Martin S. Staege, Swapna V. Daulatabad, Darius Widera, Junpeng Zhang, Adrian Meule, Ken Honjo, Olivier Pourret, Cong-Cong Yin, Zhongheng Zhang, Marco Cascella, Willy A. Flegel, Carl S. Goodyear, Zuzanna Bukowy-Bieryllo, Luca G. Campana, 전상민, Peter Brown, Large expert-curated database for benchmarking document similarity detection in biomedical literature search , DATABASE-THE JOURNAL OF BIOLOGICAL DATABASES AND CURATION , pp.1 -66 (Oct, 2019) [논문] 문창규, 전희숙, 주청, 전상민, Diol-ginsenosides from Korean Red Ginseng delay the development of type 1 diabetes in diabetes-prone biobreeding rats , JOURNAL OF GINSENG RESEARCH , pp.1 -8 (Jun, 2019) [논문] 허훈, 오혜정, 배청아, 전상민, 진혜진, 손상용, 한상욱, 이다근, Rolf A. Brekken, 함인혜, 최경숙, Targeting interleukin-6 as a strategy to overcome stroma-induced resistance to chemotherapy in gastric cancer , MOLECULAR CANCER , Vol.18 , No.1 , pp.68 -68 (Mar, 2019) [논문] 신수영, 전상민, 노유진, Association between glucose-lowering treatment and cancer metastasis among patients with preexisting type 2 diabetes and incident malignancy , INTERNATIONAL JOURNAL OF CANCER , pp.1 -32 (Sep, 2018) [논문] 전상민, 신은애, Exploring vitamin D metabolism and function in cancer , EXPERIMENTAL AND MOLECULAR MEDICINE , pp.1 -14 (Apr, 2018) [논문] 전상민, Nissim Hay, Expanding the concepts of cancer metabolism , EXPERIMENTAL AND MOLECULAR MEDICINE , pp.1 -3 (Apr, 2018) [논문] 장수환, 김신애, 이은지, 정재윤, 이종원, Shyam K Sharan, 김지선, 유현주, 이희진, 채선영, 손병호, 공경엽, 전상민, 김희정, microRNA-155 positively regulates glucose metabolism via PIK3R1-FOXO3a-cMYC axis in breast cancer , ONCOGENE , Vol.37 , No.22 , pp.2982 -2991 (Mar, 2018) [논문] 장선영, 전상민, Hyun-Jeong Ko, Seong-Ryeol Kim, Jae-Hyoung Song, Jae-Hee Ahn, Huijeong Ahn, Sung-il Yoon, Seung Goo Kang, Pyeung-Hyeun Kim, 최은지, Younggil Cha, Sungchan Cho, Dong-eun Kim, 신수영, Geun-Shik Lee, Antiviral and anti-inflammatory activity of budesonide against human rhinovirus infection mediated via autophagy activation , ANTIVIRAL RESEARCH , Vol.151 , pp.87 -96 (Mar, 2018) [논문] Nissim Hay, Maciek R. Antoniewicz, Dannielle DeWaal, Christopher P. Long, Alexander R. Terry, Krushna C. Patra, Grace Guzman, Jennifer Au, 전상민, Veronique Nogueira, Hexokinase-2 depletion inhibits glycolysis and induces oxidative phosphorylation in hepatocellular carcinoma and sensitizes to metformin , NATURE COMMUNICATIONS , Vol.9 , pp.1 -14 (Jan, 2018) [논문] 전상민, 박영준, 신수영, 정병진, 유환식, Dysregulation of NRF2 in Cancer: from Molecular Mechanisms to Therapeutic Opportunities , BIOMOLECULES & THERAPEUTICS , pp.57 -68 (Dec, 2017) [논문] 전상민, 정병진, 이선형, 장수환, 신은애, 김수열, 고현정, 최은지, 유환식, A clinical drug library screen identifies clobetasol propionate as an NRF2 inhibitor with potential therapeutic efficacy in KEAP1 mutant lung cancer , ONCOGENE , pp.1 -11 (May, 2017) [논문] 전상민, 고현정, 진영원, 김진웅, 홍은혜, 이재영, 권보은, 송재형, 허은영, 장선영, 박예정, Trans-scirpusin A showed antitumor effects via autophagy activation and apoptosis induction of colorectal cancer cells , ONCOTARGET , pp.1 -11 (Apr, 2017) [논문] 윤석준, 김나영, 임화영, He N, 이철중, 김주현, Mills G, 이혜숙, 김소민, 정유나, 송미, 김우영, 조용연, 전상민, 최진성, Cardiac glycosides display selective efficacy for STK11 mutant lung cancer , SCIENTIFIC REPORTS , pp.1 -11 (Jul, 2016) [논문] 전상민, Regulation and Function of AMPK in Physiology and Diseases , EXPERIMENTAL AND MOLECULAR MEDICINE , pp.1 -13 (Jul, 2016) [논문] 고현정, 권보은, 송재형, 송혁환, 강주은, 조성찬, 이기종, 심애리, 홍은혜, 김연정, 장선영, 김동은, 전상민, 황삼노, Antiviral Activity of Oroxylin A against Coxsackievirus B3 Alleviates Virus-Induced Acute Pancreatic Damage in Mice , PLoS ONE , pp.1 -13 (May, 2016) [논문] 전상민, Nissim Hay, Wang Qi, Xinyu Chen, Xiao-Ding Peng, Morris J. Birnbaum, Grace Guzman, Wan-Ni Yu, Spontaneous Hepatocellular Carcinoma after the Combined Deletion of Akt Isoforms , CANCER CELL , Vol.29 , No.4 , pp.523 -535 (Apr, 2016) [논문] 전상민, Nissim Hay, The double-edged sword of AMPK signaling in cancer and its therapeutic implications , ARCHIVES OF PHARMACAL RESEARCH , Vol.38 , No.3 , pp.346 -357 (Mar, 2015) [논문] 전상민, Nissim Hay, The dark face of AMPK as an essential tumor promoter , CELLULAR LOGISTICS , Vol.2 , No.4 , pp.197 -202 (Oct, 2012) [논문] 전상민, Nissim Hay, Naveedip Chandel, AMPK regulates NADPH homeostasis to promote tumour cell survival during energy stress , NATURE , Vol.485 , pp.661 -665 (May, 2012) [논문] Nissim Hay, Xu PZ, Peng XD, 전상민, Chen ML, The effect of Akt2 deletion on tumor development in Pten+/- mice. , ONCOGENE , Vol.31 , No.4 , pp.518 -526 (Jan, 2012) [논문] Nissim Hay, Chen CC, Park Y, Nogueira V, Sundararajan D, Tonic I, 전상민, Bhaskar PT, FoxOs Inhibit mTORC1 and Activate Akt by Inducing the Expression of Sestrin3 and Rictor , DEVELOPMENTAL CELL , Vol.18 , No.4 , pp.592 -604 (Apr, 2010) [논문] Nissim Hay, Bhaskar PT, Robey RB, Patra KC, Park Y, 전상민, Nogueira V, mTORC1 Hyperactivity Inhibits Serum Deprivation-Induced Apoptosis via Increased Hexokinase II and GLUT1 Expression, Sustained Mcl-1 Expression, and Glycogen Synthase Kinase 3β Inhibition , MOLECULAR AND CELLULAR BIOLOGY , Vol.29 , No.18 , pp.5136 -5147 (Sep, 2009) [논문] Nissim Hay, Chen WS, Peng XD, Wang Y, Philipson LH, Chen ML, Luo Y, Coleman K, Haschek WM, Bass J, 전상민, Xu PZ, Leptin deficiency and beta-cell dysfunction underlie type 2 diabetes in compound Akt knockout mice , MOLECULAR AND CELLULAR BIOLOGY , Vol.29 , No.11 , pp.3151 -3162 (Jun, 2009) [논문] 박주배, 최봉근, 배창대, 김은희, 성연선, 전상민, 홍경욱, A cytoskeleton-associated protein, TMAP/CKAP2, is involved in the proliferation of human foreskin fibroblasts , BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS , Vol.348 , No.1 , pp.222 -228 (Sep, 2006) [논문] 박주배, 배창대, 성연선, 안경환, 양한관, 김영일, 박기호, 최종선, 전상민, 서유신, Up-regulation of cytoskeletal-associated protein 2 in primary human gastric adenocarcinomas , JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY , Vol.129 , No.11 , pp.621 -630 (Nov, 2003) 국제학술발표 [학술회의] 전상민, NRF2 and Cancer: a paradigm shift from an outside-in perspective , 대한약학회 추계 국제학술대회 (Oct, 2020) [학술회의] 전상민, 박소현, 최은지, Regulation of AMPK and NRF2 during metabolic stress in cancer , Forum 2019: Pharmaceutical Health Science and Environmental Toxicology (Aug, 2019) [학술회의] 전상민, 김수열, 최은지, Developing NRF2 inhibitors for cancer therapy: Clobetasol propionate and beyond , Phase 1: Where Science Becomes Medicine (Jul, 2019) [학술회의] 전상민, 최은지, 박건석, LKB1 Regulates Vitamin D Signaling in Cancer , 대한약학회 봄 정기학술대회 (Apr, 2019) [학술회의] 전상민, 박소현, 최은지, Crosstalk between AMPK and NRF2 Signaling Pathways during metabolic stress in Cancer , 대한약학회 봄 정기학술대회 (Apr, 2019) [학술회의] 전상민, 박소현, 최은지, CROSSTALK BETWEEN AMPK AND NRF2 DURING METABOLIC STRESS IN CANCER , Nature Conference on Cellular Metabolism (Apr, 2019) [학술회의] 신수영, 전상민, 노유진, Metastasis-promoting and -suppressing potentials of glucose-lowering treatment: a nationwide propensity score matched cohort study , 2018 ACCP Global Conference on Clinical Pharmacy (Oct, 2018) [학술회의] 전상민, 최은지, 박소현, The role of LKB1 and AMPK in vitamin D signaling , 2018 Fall international convention of the pharmaceutical society of Korea (Oct, 2018) [학술회의] 전상민, 박소현, 김수열, 최은지, AMPK and NRF2 cooperate to promote antioxidant defense and tumor cell survival during metabolic stress , 2018 Fall international convention of the pharmaceutical society of Korea (Oct, 2018) [학술회의] 신수영, 노유진, 전상민, Metastatic risk post primary cancer in type 2 diabetes patients with incident malignancy: effect of glucose-lowering treatment , 2018 Fall International Convention of The Pharmaceutical Soecity of Korea (Oct, 2018) [학술회의] 전상민, AMPK regulates KEAP1-NRF2 pathway during metabolic stress to promote antioxidant defense in cancer. , AMPK From Mechanisms to New Therapies (Oct, 2018) [학술회의] 전상민, Drug repositioning approach to identify NRF2 inhibitors for cancer therapy: Clobetasol propionate and beyond , Forum 2018 Pharmaceutical Health Science - Environmental Toxicology (Sep, 2018) [학술회의] 전상민, 박소현, 최은지, NRF2 promotes anchorage-independent growth of LKB1-deficient cancer cells by redirecting NADPH metabolism , 2018 Fall international convention of the pharmaceutical society of Korea (Apr, 2018) [학술회의] 전상민, 이선형, 김수열, 최은지, 정병진, Cancer therapeutic strategy targeting NRF2 by clobetasol propionate and beyond , Keystone Symposia - Tumor Metabolism (Jan, 2018) [학술회의] 전상민, 신은애, Novel connection between tumor suppressor LKB1 and vitamin D signaling , 2017 Fall International Convention of The Pharmaceutical Society of Korea (Oct, 2017) [학술회의] 전상민, Accelerating precision cancer medicine by integrating cancer genomics with drug repositioning , 대한약학회 춘계국제학술대회 (Apr, 2017) [학술회의] 전상민, 정병진, 김수열, 유환식, 신은애, 최은지, 이선형, A clinical drug library screen identifies clobetasol propionate as a potent NRF2 inhibitor and a promising repurposed therapeutic agent for lung cancers with high NRF2 activity , 대한약학회 70주년 국제학술대회 (Oct, 2016) [학술회의] 전상민, Understanding metabolic adaptations for cancer therapy , 2016 Cancer Metabolism: Light in the Darkness (Sep, 2016) [학술회의] 전상민, Georgia Hatzivassiliou, 최은지, Dual activation of AMPK and NRF2 during metabolic stress defines co-operating antioxidant defense mechanisms in cancer , Keystone Symposia - Frontiers in Cancer Metabolism (Feb, 2016) [학술회의] 전상민, Integrative Approaches to Develop Novel Therapeutic Strategies by Exploring the LKB1-AMPK Paradox in Lung Cancer , 2015 Bio Korea (Apr, 2015) [학술회의] 전상민, Therapeutic Implications and Business Development by Regulation of LKB1-AMPK Pathway in Cancer , 제 1차 한중 암대사 워크숍 , pp.19 -20 (Dec, 2014) [학술회의] 전상민, Metabolism and Cancer: Old Friends are the Best Friends , 2014 Spring International Convention of The Parmaceutical Society of korea (Apr, 2014) 국내학술발표 [학술회의] 전상민, NRF2 and cancer: An emerging paradigm from an outside-in perspective , 2020 IRIDD Symposium on Metabolism and Metabolic Diseases (Dec, 2020) [학술회의] 신수영, 노유진, 전상민, Impact of NRF2 modulating antidiabetics on the risk of metastatic progression of underlying malignancy in diabetic cancer patients , 뉴노멀시대 임상약학 교육-연구-실무의 성과와 도전 (Nov, 2020) [학술회의] 전상민, GR-NRF2 axis as a novel therapeutic target of cancer metabolism , 제8회 KSBMB DDC 제주 워크숍 (Jul, 2020) [학술회의] 전상민, Understanding cancer metabolism from an outside-in perspective , 2020 대한암학회 춘계 학술대회 (Jun, 2020) [학술회의] 전상민, Cancer metabolism from an outside-in perspective , 제11회 동계학술대회 2020 KSBMB (Jan, 2020) [학술회의] 전상민, Targeting redox metabolism for cancer therapy: From the bench to the bedside , 제7회 신약개발컨소시엄 제주 워크숍 (Jul, 2019) [학술회의] 전상민, Cancer metabolism from an evolutionary perspective , Cancer Metabolism Workshop in Korea (Mar, 2019) [학술회의] 전상민, The origin of cancer from a metabolic perspective , 2018 Cancer Metabolism Workshop (Feb, 2018) [학술회의] 전상민, Targeting NRF2 for cancer therapy by drug repositioning approach , 생명약학연구회-한국약제학회 동계 심포지엄 (Feb, 2018) [학술회의] 전상민, Cancer Metabolism: Time to Rethink Warburg Effect and Cancer , 한국수지상세포학회 (Dec, 2017) [학술회의] 전상민, Drug repositioning approach to identify NRF2 inhibitors for cancer therapy , 한국프리라디칼학회 (Nov, 2017) [학술회의] 전상민, Integration of Signaling & Metabolism for Cancer Therapy , 한국생약학회 (Nov, 2017) [학술회의] 전상민, 김수열, 이선형, 최은지, 정병진, Targeting NRF2 for cancer therapy , 추계약학회 (Oct, 2017) [학술회의] 전상민, 글루코코르티코이드계 화합물을 포함하는 폐암 치료용 약학 조성물 , 대한약학회 (Oct, 2017) [학술회의] 전상민, Bridging the layers: integration of cancer genomics, signaling and metabolism network for cancer therapy , KSBMB DDC 제주 워크샵 (Jul, 2017) [학술회의] 전상민, New insights into the mechanisms of metabolic adaptation in cancer , (사)대한약학회 신약개발네트워크분과 창립기념 심포지움 (Apr, 2017) [학술회의] 전상민, Georgia Hatzivassiliou, 최은지, Co-occurring mutations in LKB1 and KEAP1 in lung cancer synergize tumor growth , 하이원 신약개발 심포지엄 (Jan, 2017) [학술회의] 전상민, 김수열, 이선형, 최은지, 정병진, Clobetasol propionate, a synthetic glucocorticoid, is a novel GSK3-dependent NRF2 inhibitor displaying promising therapeutic efficacy in KEAP1-mutant lung cancers , 하이원 신약개발 심포지엄 (Jan, 2017) [학술회의] 전상민, 최은지, Georgia Hatzivassiliou, 유환식, AMPK and NRF2 cooperate to promote tumor cell survival during metabolic stress , 하이원 신약개발 심포지엄 (Jan, 2017) [학술회의] 전상민, Exploiting Metabolic Adaptations for Cancer Therapy , 한국유방암학회 중개연구회 심포지엄 (Nov, 2016) [학술회의] 전상민, NRF2 조절을 통한 폐암 치료 신약개발 , 신약개발분과회 추계 워크숍 (Oct, 2016) [학술회의] 전상민, Dissecting the Role of AMPK in Cancer , 2016 대한신경종양학회 추계학술대회 (Sep, 2016) [학술회의] 전상민, The LKB1-AMPK and KEAP1-NRF2 pathways synergize antioxidant defense during metabolic stress in cancer , 2016 cMIG 춘계 워크숍 (Mar, 2016) [학술회의] 전상민, Georgia Hatzivassiliou, 최은지, High frequency of co-occurring mutations in LKB1 and KEAP1 in lung cancer confers combinatorial oncogenic driver pathway allowing concurrent activation of both mTORC1-mediated growth and NRF2-mediated antioxidant defense , 하이원신약개발심포지아 (Jan, 2016) [학술회의] 전상민, 최은지, 정병진, A clinical drug library screen identifies glucocorticoids as novel NRF2 inhibitors and promising repurposed therapeutics for lung cancers with high NRF2 activity. , 하이원신약개발심포지아 (Jan, 2016) [학술회의] 전상민, Dual activation of AMPK and NRF2 during metabolic stress is a critical fail-safe mechanism for metabolic adaptation in cancer , 제5차 암대사 워크숍 (Nov, 2015) [학술회의] 전상민, Novel therapeutic opportunities behind the LKB1-AMPK paradox in lung cancer , The 2nd KSBMB DDC JEJU WORKSHOP (Jul, 2015) [학술회의] 전상민, Business development by regulation of metabolic pathway in cancer and challenges for clinical application , 2015년 한국임상암학회 제 13차 정기 심포지움 및 총회 (May, 2015) [학술회의] 전상민, Understanding the LKB1-AMPK pathway in cancer for novel therapeutic interventions , 2015년 생명 약학 연구회 동계 심포지엄 (Feb, 2015) [학술회의] 전상민, Developing novel anti-cancer strategies integrating cancer genomics, signaling and metabolism network , 2014 Lee Gil Ya Cancer and Diabetes Institute Symposium , pp.31 -33 (Nov, 2014) [학술회의] 전상민, Exploring the LKB1-AMPK paradox and Its Implications for Cancer Therapy , 제 38회 세포생물학회 하계 학술대회 , pp.31 -31 (Jul, 2014) [학술회의] 전상민, Exploring the LKB1 Paradox in Cancer: A Tumor Suppressor with a Key Role in Tumor Stress Adaptation and Its Therapeutic Implications , 동아 제 1차 항암 미니 심포지엄 (Apr, 2014) [학술회의] 전상민, Exploring the LKB1 paradox: a tumor suppressor with a key role in tumor stress adaptation , 제5회 생화학분자생물학회 동계학술대회 (Jan, 2014) [학술회의] 전상민, Anneleen Daemen, Leisa Johnson, Georgia Hatzivassiliou, David Stokoe, Exploring the LKB1-AMPK paradox: A tumor suppressor pathway with a key role in tumor stress adaptation , 제1회 아주대학교 의약학 공동 심포지움 (Sep, 2013) 저서 및 번역 [저서] 전상민, 한선영, 김민선, 김성연, 김은희, 김희진, 박광식, 이상규, 이윤희, 임경민, 정광원, 정영석, 정재훈, 정주희, 창동신, 천경수, 기성환, Casarett & Doull's Essentials of Toxicology, 3rd edition (Sep, 2018) [저서] 전상민, 최성숙, 이무열, 이병훈, 박광식, 허문영, 김환묵, 천경수, 이상규, 양미희, 김대경, 신태용, 정주희, 유환수, 정진호, 김형식, 정규혁, 김은희, 김영철, 이은영, 배옥남, 김성연, 윤여표, 정태천, 기성환, 오승현, 이효종, 신윤용, 임경민, 이윤희, 배지현, 정세영, 박애경, 이주영, 정혜광, 김영미, 김규봉, 정영석, 박영자, 노윤석, 김상겸, 창동신, 예방약학 8판 (Mar, 2017) [저서] 전상민, 임상독성학 , pp.221~227 (Mar, 2015)
특허 및 기타	[특허] 전상민, 글루코코르티코이드계 화합물을 포함하는 비소세포성 폐암 치료용 약학 조성물 (등록) (10-2000425) (Jul, 2019) [특허] 전상민, 글루코코르티코이드계 화합물을 포함하는 비소세포성 폐암 치료용 약학 조성물 (등록) (10-2000424) (Jul, 2019) [특허] 전상민, 글루코코르티코이드계 화합물을 포함하는 비소세포성 폐암 치료용 약학 조성물 (등록) (10-1978629) (May, 2019) [특허] 전상민, 글루코코르티코이드계 화합물을 포함하는 비소세포성 폐암 치료용 약학 조성물 (등록) (10-1892908) (Aug, 2018) [특허] 전상민, 글루코코르티코이드계 화합물을 포함하는 폐암 치료용 약학 조성물 (출원) (201680064090.8) (R0420CN) (May, 2018) [특허] 전상민, 글루코코르티코이드계 화합물을 포함하는 폐암 치료용 약학 조성물 (출원) (15/772,714) (R0420US) (May, 2018) [특허] 전상민, 글루코코르티코이드계 화합물을 포함하는 폐암 치료용 약학 조성물 (출원) (PCT/KR2016/012534) (Nov, 2016) [특허] 전상민, 글루코코르티코이드계 화합물을 포함하는 비소세포성 폐암 치료용 약학 조성물 (출원) (10-2015-0153296) (Nov, 2015) [특허] 전상민, 글루코코르티코이드계 화합물을 포함하는 비소세포성 폐암 치료용 약학 조성물 (출원) (10-2015-0153089) (Nov, 2015)

빠른 이동 메뉴